Weill Cornell Cancer Center — New York, New York

Weill Cornell Cancer Center is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Weill Cornell Cancer Center has participated in 3 clinical trials.

Therapeutic areas: Myeloid Malignancy, Advanced Malignancies, Hematologic Malignancies.

Sponsors: Aprea Therapeutics, Celldex Therapeutics, Infinity Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Cancer Center?

Weill Cornell Cancer Center has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Cancer Center conducted?

Weill Cornell Cancer Center has 3 clinical trials on record. Their work covers Myeloid Malignancy, Advanced Malignancies, Hematologic Malignancies.

Is Weill Cornell Cancer Center accredited by Crixeo Health?

Weill Cornell Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.